These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35625764)

  • 21. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
    Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
    Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized Medicine and Resurrected Hopes for the Management of Alzheimer's Disease: A Modular Approach Based on GSK-3β Inhibitors.
    Arafa RK; Elghazawy NH
    Adv Exp Med Biol; 2017; 1007():199-224. PubMed ID: 28840559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal autophagy: self-eating or self-cannibalism in Alzheimer's disease.
    Ułamek-Kozioł M; Furmaga-Jabłońska W; Januszewski S; Brzozowska J; Sciślewska M; Jabłoński M; Pluta R
    Neurochem Res; 2013 Sep; 38(9):1769-73. PubMed ID: 23737325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synapse as a treatment avenue for Alzheimer's Disease.
    Peng L; Bestard-Lorigados I; Song W
    Mol Psychiatry; 2022 Jul; 27(7):2940-2949. PubMed ID: 35444256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
    Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Qingyangshen mitigates amyloid-β and Tau aggregate defects involving PPARα-TFEB activation in transgenic mice of Alzheimer's disease.
    Iyaswamy A; Krishnamoorthi SK; Zhang H; Sreenivasmurthy SG; Zhu Z; Liu J; Su CF; Guan XJ; Wang ZY; Cheung KH; Song JX; Durairajan SSK; Li M
    Phytomedicine; 2021 Oct; 91():153648. PubMed ID: 34332287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
    Zhang ZX; Zhao RP; Wang DS; Li YB
    Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy in Alzheimer's disease pathogenesis: Therapeutic potential and future perspectives.
    Zhang Z; Yang X; Song YQ; Tu J
    Ageing Res Rev; 2021 Dec; 72():101464. PubMed ID: 34551326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.
    Lam S; Hérard AS; Boluda S; Petit F; Eddarkaoui S; Cambon K; ; Picq JL; Buée L; Duyckaerts C; Haïk S; Dhenain M
    Acta Neuropathol Commun; 2022 Aug; 10(1):112. PubMed ID: 35974399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications.
    Gu Z; Cao H; Zuo C; Huang Y; Miao J; Song Y; Yang Y; Zhu L; Wang F
    Neurobiol Dis; 2022 Oct; 173():105855. PubMed ID: 36031168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapamycin, Autophagy, and Alzheimer's Disease.
    Cai Z; Yan LJ
    J Biochem Pharmacol Res; 2013 Jun; 1(2):84-90. PubMed ID: 23826514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease.
    Friedman LG; Qureshi YH; Yu WH
    Neurotherapeutics; 2015 Jan; 12(1):94-108. PubMed ID: 25421002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of Dcf1 Reduces Amyloid-β Aggregation and Mitigates Memory Deficits.
    Li WH; Gan LH; Ma FF; Feng RL; Wang J; Li YH; Sun YY; Wang YJ; Diao X; Qian FY; Wen TQ
    J Alzheimers Dis; 2021; 81(3):1181-1194. PubMed ID: 33896839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.
    Fan SJ; Huang FI; Liou JP; Yang CR
    Cell Death Dis; 2018 May; 9(6):655. PubMed ID: 29844403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.